Skip to content

Apotheek Legrand

Active
Private limited companyfounded 199234 yrs activeMolenstraat 1A, 8980 Zonnebeke, BelgiumKBO/BCE: BE 0446.469.818

Apotheek Legrand has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €359k and a net result of €241k. Equity is shrinking by ~6.6% per year across the filed fiscal years. Its solvency ranks better than 66% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
96 / 100
Excellent▲ +5 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency86▲+4
Growth58=
Stability100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 1.54 against 1.39 in 2024), and 46.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 34 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
53.6%
Return on assets
36%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 d early
2024
17 d early
2023
30 d late
2022
14 d early
2021
31 d late
2020
30 d late
2019
41 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€359k▲ 0.1%
2024 · €359k
2018: €564k 2019: €565k 2020: €523k 2021: €519k 2022: €488k 2023: €348k 2024: €359k
2018 → 2025
Total assets
€670k▼ 5.5%
2024 · €709k
2018: €778k 2019: €680k 2020: €697k 2021: €714k 2022: €544k 2023: €503k 2024: €709k
2018 → 2025
Net result
€241k▲ 23.2%
2024 · €196k
2018: €63k 2019: €1k 2020: €-42k 2021: €-4k 2022: €-31k 2023: €160k 2024: €196k
2018 → 2025
Working capital
€168k▲ 22.6%
2024 · €137k
2018: €467k 2019: €478k 2020: €443k 2021: €445k 2022: €420k 2023: €264k 2024: €137k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€519k-€488k▼ 5.9%€348k▼ 28.7%€359k▲ 3.1%€359k▲ 0.1%
Operating result€-4k-€-30k▼ 626%€159k€197k▲ 24.4%€244k▲ 23.8%
Net result€-4k-€-31k▼ 682%€160k€196k▲ 22.3%€241k▲ 23.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-100k€0€100k€200kOperating result 2021: €-4k€-4kNet result 2021: €-4k€-4kOperating result 2022: €-30k€-30kNet result 2022: €-31k€-31kOperating result 2023: €159k€159kNet result 2023: €160k€160kOperating result 2024: €197k€197kNet result 2024: €196k€196kOperating result 2025: €244k€244kNet result 2025: €241k€241k20212022202320242025
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 24% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €670k
Fixed assets €192k▼ 13.8%
Current assets €478k▼ 1.7%
Equity and liabilities €670k
Equity €359k▲ 0.1%
Debt €310k▼ 11.2%
The debt ratio falls from 49.4% to 46.4%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€276k
2024 · €222k
Cash flow
€273k
2024 · €220k
Solvency
53.6%
2024 · 50.6%
Current ratio
1.54
2024 · 1.39
Quick ratio
0.89
2024 · 0.85
Debt / equity
0.86
2024 · 0.97
ROE
67.1%
2024 · 54.5%
ROA
36.0%
2024 · 27.6%
Interest coverage
72.89
2024 · 62.10
Debt
€310k
2024 · €350k
Debt ≤ 1 year
€310k
2024 · €350k
Income taxes
€837
Staff costs
€70k
2024 · €83k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€709k€670k
Fixed assets21/28€222k€192k
Tangible fixed assets22/27€222k€192k
Land and buildings22€74k€68k
Plant, machinery and equipment23€147k€123k
Furniture and vehicles24€944€653
Current assets29/58€486k€478k
Stocks and contracts in progress3€189k€202k
Stocks30/36€189k€202k
Amounts receivable within one year40/41€125k€116k
Trade receivables40€106k€110k
Other amounts receivable41€19k€6k
Cash at bank and in hand54/58€169k€156k
Deferred charges and accrued income490/1€3k€4k
Equity and liabilities
Total equity and liabilities10/49€709k€670k
Equity10/15€359k€359k
Contributions10/11€62k€62k=
Reserves13€297k€297k
Tax-exempt reserves132€14k€14k=
Distributable reserves133€283k€284k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€350k€310k
Amounts payable within one year42/48€350k€310k
Trade debts44€82k€57k
Suppliers440/4€82k€57k
Taxes, remuneration and social security45€15k€12k
Taxes450/3€275€978
Remuneration and social security454/9€15k€11k
Other amounts payable47/48€253k€242k
Income statement Code20242025
Remuneration, social security and pensions62€83k€70k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€24k€32k
Other operating charges640/8€2k€2k
Gross operating margin9900€307k€348k
Operating profit (loss)9901€197k€244k
Financial income75/76B€2k€1k
Recurring financial income75€2k€1k
Financial charges65/66B€4k€4k
Recurring financial charges65€4k€4k
Profit (loss) for the period before taxes9903€196k€242k
Income taxes67/77-€837
Profit (loss) for the period9904€196k€241k
Profit (loss) for the period to be appropriated9905€196k€241k
Appropriation of the result
Profit (loss) to be appropriated9906€196k€241k
Transfer from equity791/2€0-
Transfer to equity691/2€11k€273
To other reserves6921€11k€273
Profit to be distributed694/7€185k€241k
Return on contributions (dividend)694€0-
Directors or managers695€185k€241k
Social balance
Average headcount (FTE)90871.71.3

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Highest result since 2018net €241k ▲23.2%
Operating result €244k, net result €241k, both a record.
14-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
31-12
Financial Back to profitnet €160k
Net result €160k after 3 loss-making years.
17-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Liquidity triplescurrent ratio 8.71
Current ratio from 3.29 to 8.71; short-term debt falls from €195k to €55k.
31-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
31-12
Financial Weakest financial yearnet €-42k ▼3050%
Net result drops to €-42k, the lowest in the series; recovery starts the following year.
10-09
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 41 days late
2019
30-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
21-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-05
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zonnebeke · 1 establishment unit since 1992
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Molenstraat 1A8980 Zonnebeke
Ground area
1,141 m²
Building footprint
498 m²
Volume, LiDAR
3,017 m³
2 parcels, Flanders · tallest building 10.8 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Legrand
Molenstraat 1 A, 8980 ZonnebekeWarehousing and support activities for transportation
since 19922.056.798.688
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
33019D1206/00A000 Flanders 615 m² 1 · 216 m² 10.8 m · 3 fl.
33019D1113/00K000 Flanders 526 m² 1 · 283 m² 10.5 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 75 EUR awarded · 163 EUR paid
Year Entries awardedpaid
2023 1 75 EUR163 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 75 EUR · 163 EUR paid · Fonds voor Innoveren en Ondernemen

Recognitions · licences · registrations

Food safety, FASFC

1 site
Zonnebeke2.056.798.688
1 permission
Apotheek (LM>3 maand) · since 15-09-2008

Similar companies · same sector, comparable size

Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,454 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded23-01-1992
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 34 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.